Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × edoxaban × Clear all

Phase

Status

Completed 5 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hemostatic Disorders 1

Interventions

Cisplatin 350 Oxaliplatin 258 Capecitabine 256 Radiotherapy 238 Docetaxel 219 Carboplatin 219 Cyclophosphamide 218 Gemcitabine 214 Drug Therapy 209 apatinib 200 Paclitaxel 200 Bevacizumab 191 camrelizumab 188 Fluorouracil 186 sintilimab 129 Irinotecan 124 Blood Specimen Collection 124 Dexamethasone 122 Etoposide 117 Radiosurgery 113 toripalimab 110 pembrolizumab 110 Surgical Procedures, Operative 110 Pemetrexed 107 anlotinib 105 S 1 (combination) 104 Surveys and Questionnaires 102 Leucovorin 99 Doxorubicin 97 Rituximab 93

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03570281 2018-06-26

ENCHASE

Samsung Medical Center

Phase 2/3 Unknown

Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡